- Home
- BDL vs DXR Comparison
BDL vs DXR Comparison
Compare BDL & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDL
- DXR
- Stock Information
- Founded
- BDL 1959
- DXR 1970
- Country
- BDL United States
- DXR United States
- Employees
- BDL N/A
- DXR N/A
- Industry
- BDL Restaurants
- DXR Medical/Dental Instruments
- Sector
- BDL Consumer Discretionary
- DXR Health Care
- Exchange
- BDL Nasdaq
- DXR Nasdaq
- Market Cap
- BDL 48.0M
- DXR 42.6M
- IPO Year
- BDL N/A
- DXR N/A
- Fundamental
- Price
- BDL $24.50
- DXR $9.01
- Analyst Decision
- BDL
- DXR Strong Buy
- Analyst Count
- BDL 0
- DXR 1
- Target Price
- BDL N/A
- DXR $24.75
- AVG Volume (30 Days)
- BDL 1.0K
- DXR 7.6K
- Earning Date
- BDL 01-02-2025
- DXR 01-01-0001
- Dividend Yield
- BDL 2.04%
- DXR N/A
- EPS Growth
- BDL N/A
- DXR N/A
- EPS
- BDL 1.64
- DXR 0.35
- Revenue
- BDL $185,457,000.00
- DXR $154,205.00
- Revenue This Year
- BDL N/A
- DXR N/A
- Revenue Next Year
- BDL N/A
- DXR N/A
- P/E Ratio
- BDL $14.95
- DXR $25.85
- Revenue Growth
- BDL 8.71
- DXR N/A
- 52 Week Low
- BDL $24.32
- DXR $7.11
- 52 Week High
- BDL $29.72
- DXR $10.04
- Technical
- Relative Strength Index (RSI)
- BDL 33.81
- DXR 49.80
- Support Level
- BDL $24.65
- DXR $8.53
- Resistance Level
- BDL $25.73
- DXR $9.10
- Average True Range (ATR)
- BDL 0.20
- DXR 0.47
- MACD
- BDL -0.01
- DXR -0.01
- Stochastic Oscillator
- BDL 29.86
- DXR 35.71
About BDL Flanigan's Enterprises Inc.
Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service and Package stores consist of retail liquor sales and related items. The company generates maximum revenue from Restaurant segment.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.